Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha take a look at the debate around when the COVID-19 pandemic might turn endemic

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha review the COVID-19 situation in India, and also talk about the possibilities of the Corbevax vaccine

Immunologist Dr. Satyajit Rath discusses the rising number of Omicron cases in major countries, as well as the high positivity rate in metropolitan cities in India

Immunologist Dr. Satyajit Rath talks about the Omicron variant, which seems to have displaced Delta in India and could infect more people than its predecessor

Today we look at new threats facing Wet’suwet’en water protectors in Canada, the killing of a Palestinian man by Israeli forces in the West Bank, and more

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha discuss the emerging Omicron situation and new vaccines that have received the emergency use approval in India, including the oral-drug Molnupiravir

With 7-8% joblessness for the past few years, urban job seekers are helpless and hopeless. An equally alarming trend is the fall of the work participation rate itself in cities and towns

As debates heat up on various rules and regulations on commuting during the pandemic, Dr. Satyajit Rath talks about the xenophobic nature of the current international restrictions on air travel

A new report by the New York Times shows how the Narendra Modi government completely disregarded scientific evidence to further its immediate political interests during the first and second waves of COVID-19

Today we look at a strike by government scheme workers in India, a violent eviction drive by police in the Indian state of Assam, and more

Newsclick’s Prabir Purkaystha talks about the recent New York Times report which examines the Indian scientific establishment’s approach ahead of the second wave of the COVID-19. The report suggests that health preparations suffered due to politics

Dr. Satyajit Rath discusses the studies of Delta variant of COVID-19, protection by the vaccine, and the need for booster doses and probability of further mutation